Invesco Biotechnology & Genome ETF
PBE
PBE
102 hedge funds and large institutions have $92.4M invested in Invesco Biotechnology & Genome ETF in 2024 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 14 increasing their positions, 35 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
60% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 35
Holders
102
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.21M | |
| 2 | +$589K | |
| 3 | +$466K | |
| 4 |
Two Sigma Investments
New York
|
+$433K |
| 5 |
Goldman Sachs
New York
|
+$408K |
Top Sellers
| 1 | -$6.7M | |
| 2 | -$2.08M | |
| 3 | -$709K | |
| 4 |
CW
CreativeOne Wealth
Overland Park,
Kansas
|
-$514K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$464K |